TY - JOUR
T1 - Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in raw 264.7 cells
AU - Woo, Chang Hoon
AU - Lim, Jae Hyang
AU - Kim, Jae Hong
PY - 2004/12/1
Y1 - 2004/12/1
N2 - We have identified a novel signaling pathway that leads to expression of matrix metalloproteinase-9 (MMP-9) in in urine macrophages in response to the bacterial endotoxin, LPS. We showed that p38 kinase was essential for this induction and observed that LPS-induced MMP-9 expression was sensitive to rottlerin, a putative protein kinase Cδ (PKCδ) inhibitor. However neither infection with a retrovirus expressing a dominant negative mutant of PKCδ nor down-regulation of PKCδ by prolonged PMA treatment affected MMP-9 expression, thus excluding involvement of PKCδ. Interestingly, LPS-induced MMP-9 expression and p38 kinase phosphorylation were shown to be suppressed by the antioxidant N-acetylcysteine and the flavoenzyme inhibitor diphenyleneiodonium chloride, but not by pyrrolidine dithiocarbamate, an NF-κB inhibitor. In addition, LPS was found to induce the production of mitochondrial reactive oxygen species (ROS) and this effect was rottlerin-sensitive, suggesting an inhibitory effect of rottlerin on mitochondrial ROS. LPS-induced MMP-9 expression and p38 kinase phosphorylation were also inhibited by rotenone, a specific inhibitor of mitochondrial complex I, supporting the role of mitochondrial ROS in LPS signaling to MMP-9. Finally, we showed that the ROS-p38 kinase cascade targets the transcription factor AP-1. Taken together, our findings identify a ROS-p38 kinase-AP-1 cascade as a novel pathway mediating LPS signaling to MMP-9 expression in macrophages.
AB - We have identified a novel signaling pathway that leads to expression of matrix metalloproteinase-9 (MMP-9) in in urine macrophages in response to the bacterial endotoxin, LPS. We showed that p38 kinase was essential for this induction and observed that LPS-induced MMP-9 expression was sensitive to rottlerin, a putative protein kinase Cδ (PKCδ) inhibitor. However neither infection with a retrovirus expressing a dominant negative mutant of PKCδ nor down-regulation of PKCδ by prolonged PMA treatment affected MMP-9 expression, thus excluding involvement of PKCδ. Interestingly, LPS-induced MMP-9 expression and p38 kinase phosphorylation were shown to be suppressed by the antioxidant N-acetylcysteine and the flavoenzyme inhibitor diphenyleneiodonium chloride, but not by pyrrolidine dithiocarbamate, an NF-κB inhibitor. In addition, LPS was found to induce the production of mitochondrial reactive oxygen species (ROS) and this effect was rottlerin-sensitive, suggesting an inhibitory effect of rottlerin on mitochondrial ROS. LPS-induced MMP-9 expression and p38 kinase phosphorylation were also inhibited by rotenone, a specific inhibitor of mitochondrial complex I, supporting the role of mitochondrial ROS in LPS signaling to MMP-9. Finally, we showed that the ROS-p38 kinase cascade targets the transcription factor AP-1. Taken together, our findings identify a ROS-p38 kinase-AP-1 cascade as a novel pathway mediating LPS signaling to MMP-9 expression in macrophages.
UR - http://www.scopus.com/inward/record.url?scp=9144234780&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.173.11.6973
DO - 10.4049/jimmunol.173.11.6973
M3 - Article
C2 - 15557194
AN - SCOPUS:9144234780
SN - 0022-1767
VL - 173
SP - 6973
EP - 6980
JO - Journal of Immunology
JF - Journal of Immunology
IS - 11
ER -